Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborators:
Susan G. Komen Breast Cancer Foundation
Amgen
Information provided by (Responsible Party):
Thomas Jefferson University
ClinicalTrials.gov Identifier:
NCT01349088
First received: May 4, 2011
Last updated: January 29, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Estimated Study Completion Date: September 2018
  Estimated Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)